BUFFALO, N.Y. — A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established.

A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking semaglutide and tirzepatide, popular drugs for type 2 diabetes and obesity. In ...

Learn how to prevent bindness by actively monitoring your vision and knowing how to spot the warning signs.

Your eyes are more than just windows to the soul — they’re also mirrors of your health. Subtle changes in the way they look, feel, or function can be early warning signs of deeper issues. From liver ...

Ozempic blindness isn’t a real diagnosis. It’s a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare eye condition known as NAION (non-arteritic anterior ischemic optic ...

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for type 2 diabetes and weight loss. Medications such as Ozempic, Wegovy, Mounjaro ...

The little blue pill that revolutionized bedroom performance comes with potential risks that extend far beyond its intended target area. While Viagra helps millions of men overcome erectile ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established. That is the ...

Vision changes can happen for a number of reasons, some of which are no major cause for concern, such as dry eye or fatigue. But others are serious enough to warrant a trip to the emergency department ...